1 ml phosphate-buffered saline (PBS) at 20 C were added 1.0 mCi I (Amersham Corp., Arlington Heights, Ill.), 25 pg lactoperoxidase (B grade; Calbiochem-Behring Corp., La Jolla, Calif.), and successive 10-pl pulses of H•O2 (0.3 mM, 1 mM, 3 mM, and 9 mM) at 5-rain intervals. Cells were washed twice in PBS and extracted in lysis buffer (0.5% Nonidet-P40 [NP-40, Particle Data Laboratories, Ltd., Elmhurst, Ill.l; 50 mM Tris; 150 mM NaCI; 0.02% NAN3; 5 mM EDTA; 50 ~M phenylmethylsulfonyl fluoride; 0.2 TIU/ml Aprotinin [Sigma Chemical Co., St. Louis, Mo.]; 1 pg/ml pepstatin A [Sigma Chemical Co.]; and 50 mM iodoacetamide, pH 8.0) for 30 min at 4°C. Nuclei were removed by eentrifugation at 5,000 g for 20 min.
Immunoprecipitation and Gel Electrophoresis. Immunoprecipitations were with -5 pg antibody per extract from 2 × 107 cells. After a 1-h incubation on ice, antigen-antibody complexes were collected by the addition of 10 pl of 10% fixed Staphylococcus aureus (staph A) Cowan I strain (Tufts New England Enzyme Center, Boston, Mass.). For the rat antibodies that do not bind to protein A directly, the staph A was precoated with affinity-purified mouse (SJL/J) anti-rat Ig and washed twice before addition to the cell extract. After 45 min on ice, the staph Aantibody-antigen complexes were washed three times in washing buffer (0.5% NP-40, 0.45 M NaCI, 50 mM Tris, 5 mM KI, and 0.02% NaNa, pH 8.3), and then extracted with sample buffer for gel electrophoresis. Immunoprecipitates were analyzed either by (a) 10% onedimensional sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE; 16); (b) 10% SDS-PAGE using N,N'-diallyitartardiamide (DATD) cross-linked instead of bis-acrylamide (17) ; or (c) two-dimensional gels with a nonequilibrium charge separation in the first dimension (18) , using a 4:1 ratio ofpH 3.5-10 to pH 8-9.5 ampholines (LKB Western, Pleasant Hill, Calif.), and 10% SDS-PAGE in the second dimension. Molecular weight markers (Pharmacia Fine Chemicals, Piscataway, N. J.) run on each gel were visualized by staining with Coomassie Brilliant Blue. Autoradiography was with intensifying screens (Cronex Lightningplus; DuPont Instruments, Wilmington, Del.) using Kodak X-Omat R film (Eastman Kodak Co., Rochester, N. Y.) at -70°C.
T Cell Cytotoxicity. Cytotoxic T cells were obtained by immunizing C57BL/6 male mice, aged 2-3 mo, with 3 × 107 P815 (DBA/2 mastocytoma) cells intraperitoneally. P815 was carried in vivo by intraperitoneal injection of 107 cells into DBA/2 mice every 5-10 d. 11 d after immunization, spleen cells were used as the source of cytotoxic effectors. Cytotoxicity was assessed against SlCr-labeled P815 target cells, labeled by incubating 107 cells in 100 pCi ~Cr in 0.5 ml at 37°C for 1 h. Assays were in round-bottomed microtiter plates (Linbro Chemical Co., Hamden, Conn.), using 0.1 ml target cells (2 × 10 n cells/ml) and 0.1 ml spleen effector cells in varying concentration to give spleen cell:target ratios of 100:1, 50:1, 25:1, 12:1, and 6:1, with triplicate samples of each concentration. The cell mixture was pelleted by centrifugation at 100 g for 3 min and incubated for 4 h at 37°C in 5% CO2. After centrifugation at 600 g for 10 min, 0.1 ml of the supernate was removed for determination of 51Cr released. Cytotoxicity was determined as previously described (19) . Killing is expressed as lytic units per 107 spleen cells. One lytic unit is defined as the number of spleen cells necessary to specifically lyse 40% of the target cells. Triplicate killing curves were derived for each cell treatment. For trypsinization of effector cells before the assay, spleen cells were collected and washed in PBS without fetal calf serum, and 0.5-ml aliquots containing 2 × 107 cells were incubated with varying amounts of trypsin [L(tosylamide-2-phenyl)-ethyl-chloromethyl ketone trypsin; Worthington Biochemical Corp., Freehold, N. J.] for 10 min at 37°C. The reaction was stopped by the addition of 10 ml PBS containing 10% fetal calf serum. The cells were washed twice and then used as effectors.
Blocking of Cytotoxicity by Monoclonal Antibodies. Spleen effector cells at 2 × 107 cells/ml were incubated with 20 #g monoclonal antibody for 30 min on ice, followed by the addition of an equal volume of medium containing SJL/J anti-rat Ig at 1:25 dilution. After another 30 min on ice, the cells were diluted for use as effectors without washing.
Results
Specificities of the Antibodies. Three monoclonal antibodies that each recognize a distinct Lyt-2 or Lyt-3 specificity were used in parallel studies for analysis of the macromolecular antigens. The reactivities of the anti-Lyt-2.2 (19/178) and the anti° Lyt-2 (53-6.7) antibodies were identical throughout and are consistent with a close spatial relationship of the two antigenic determinants. This was further supported by blocking studies, in which either antibody, if added initially to viable cells, showed complete blocking of the other (data not shown). A third antibody (53-5) was identified as reacting with an Lyt-3 specificity based upon studies that showed complete blocking of its binding after pretreatment of viable cells with anti-Lyt-3 alloantibodies (data not shown). This latter antibody (53-5) binds to cells from a l l strains examined so far, but shows a >200-fold higher affinity for Lyt-3.2-bearing cells than for Lyt-3.1-bearing cells (data not shown).
Characteristics of the Lyt-2, Lyt-3 Macromolecule. Immunoprecipitations with all three antibodies from NP-40 extracts of 12SI-labeled thymocytes showed identical patterns on S D S -P A G E (Fig. 1) . Under reducing gel conditions, distinct, heavily labeled proteins of 34,000 and 38,000 Mr were seen. A third protein that migrated as a broad FIo. 1. Immunoprecipitation of Lyt-2 and Lyt-3 from surface lzSI-labeled BALB/cNHz thymocytes. Immunoprecipitated proteins were electrophoresed on 10% polyacrylamide gels in the presence of SDS under both reducing and nonreducing conditions. Monoclonal antibodies used for immunoprecipitation were (1) anti-Lyt-2.2 (19/178); (2) anti-Lyt-2 (53-6.7); (3) anti-Lyt-3 (53-5); (4) anti-T200 (30-G12); (5) background (staph A alone).
band at 30,000 Mr was also specifically precipitated, although this species was not labeled as heavily as the other two species. When analyzed under nonreducing gel conditions, each antibody specifically precipitated proteins of 140,000 and 65,000-75,000 Mr. The 65,000-75,000 Mr protein(s) migrated as a broad band. This band is shown below to be composed of several kinds of dimers of the 30,000, 34,000, and 38,000 Mr subunits seen under reducing conditions. In some experiments, the 30,000 Mr subunit was seen under nonreducing gel conditions after immunoprecipitation with anti-Lyt-3, but not after immunoprecipitation with anti-Lyt-2 (Fig. 2) . Under reducing gel conditions, the 30,000 Mr subunit was seen after immunoprecipitation with both anti-Lyt-2 and anti-Lyt-3.
Lyt-2 and Lyt-3 Antigens Are on the Same Macromolecule. We used monoclonal antiLyt-2 and anti-Lyt-3 antibodies conjugated on Sepharose to show that both Lyt-2 and Lyt-3 antigens are on the same macromolecule. A detergent lysate from 125I-labeled thymocytes was divided into three equal portions that were (a) given no treatment, (b) passed through the anti-Lyt-2 absorbent, or (c) passed through the antiLyt-3 absorbent. Each portion was then subjected to immunoprecipitation with antiLyt-2.2, anti-Lyt-2, anti-Lyt-3, and anti-T200 (as a control). The results (Table I) showed that the anti-Lyt-2 absorbent removed reactivity with both anti-Lyt-2 and anti-Lyt-3 antibodies, but not with anti-T200. Similarly, the anti-Lyt-3 absorbent removed reactivity with anti-Lyt-3 but left some reactivity with anti-Lyt-2. Gel analysis of the Lyt-2 +, Lyt-3-material showed a 70,000 Mr protein under nonreducing conditions that, under reducing conditions, ran as the 38,000 and 34,000 Mr subunits (data not shown). These data show that the Lyt-2 and Lyt-3 antigens are co-expressed on the same macromolecules, but that a small amount of Lyt-2 +, Lyt-3-material exists in the detergent lysates.
Lyt-2 and Lyt-3 Antigens Reside on Individual Subunits. Lyt-2 and Lyt-3 antigens were identified on individual subunits by reduction of the molecule in detergent extracts (10 mM dithioerythritol, 3 h, 4°C) and alkylation (250 mM iodoacetamide) before immunoprecipitation with anti-Lyt-2 and anti-Lyt-3 antibodies. Both the anti-Lyt-2.2 and anti-Lyt-2 immunoprecipitated the 34,000 and 38,000 Mr polypeptides but not the 30,000 Mr polypeptide, whereas the anti-Lyt-3 antibody reacted with the 30,000 Mr polypeptide but not the 34,000 or 38,000 Mr polypeptides (Fig. 3) . These patterns of reactivity were the same whether the gels were run under reducing or nonreducing conditions, indicating that the initial reduction of the cell lysate was complete. Therefore, the Lyt-3 antigenic determinant (as identified by rat monoclonal antibody 53-5) is on the 30,000 M~ subunit, whereas the Lyt-2.2 and Lyt-2 antigenic determinants (as identified by monoclonal antibodies 19/178 and 53-6.7) reside on either the 34,000 or 38,000 Mr subunits or both. As noted above, small amounts of Lyt-2 +, Lyt-3-material was identified using immunoadsorbent columns. Similarly, some immunoprecipitation experiments revealed small amounts of free Lyt-3 subunit (30,000 Mr) in nonreduced detergent lysates (Fig. 2) . Subunit Composition of the Lyt-2,Lyt-3 Macromolecule. "lZwo-dimensional SDS-PAGE of the Lyt-2,Lyt-3 macromolecule provided additional information about the subunit composition. An anti-Lyt-2 immunoprecipitate was electrophoresed under nonreduc-ing conditions on 10% D A T D cross-linked SDS tube gels, followed by electrophoresis in the second dimension under reducing conditions on 12.5% bisacrylamide-acrylamide slab gels (Fig. 4) . This analysis showed that the 140,000-Mr species seen under nonreducing conditions is composed of all three of the 38,000, 34,000, and 30,000 Mr subunits. A larger macromolecule (>200,000 Mr) also reduced to the same three subunits, whereas the 65,000-75,000-Mr material was composed of at least two kinds of molecules, including dimers of (a) the 38,000 and 30,000 Mr species, and (b) the 34,000 and 30,000 Mr species. The existence of 34,000-34,000, 38,000-38,000, and 38,000-34,000 Mr dimers is not proven or disproven in Fig. 4 . However, the Lyt-2+,Lyt-3 -material identified by use of immunoadsorbent columns (see above) consisted of only 38,000-34,000 Mr dimers and not 38,000-38,000 or 34,000-34,000 Mr dimers. Therefore, three of the six possible dimeric combinations of the 38,000, 34,000, and 30,000 Mr subunits have been positively identified. Interestingly, these three combinations are all heterodimers (dimers of nonidentical subunits).
Two-Dimensional (Charge vs. Size) Separation of Lyt-2,Lyt-3
Macromolecules from Thymocytes. Two-dimensional gels of an Lyt-2 immunoprecipitate run under reducing conditions showed that the three subunits run with very basic charges (Fig. 5) .The Lyt-3 subunit (30,000 Mr) is the most basic species and was not seen in earlier twodimensional gel experiments (14) where it had migrated off the basic end of the gel. The Lyt-2 subunits (34,000 and 38,000 Mr) were also very basic. Under nonreducing conditions, the 65,000-75,000 Mr material clearly separated into two species, with the higher molecular weight species migrating with a more acidic charge (Fig. 5) . Similarly, the 140,000 and 200,000 Mr species showed a more acidic charge than any of the three individual subunits. This result may be attributed to (a) the macromolecule, because it is composed of disulfide-bonded subunits, may retain some of its conformation under nonreducing conditions that mask some of the basic charge of its subunits; or (b) yet another subunit exists as part of the macromolecule that has not been identified because it does not label with 125I-lactoperoxidase on viable cells; or   FIG. 4 . Two-dimensional ~el electrophoresis of the Lyt-2,Lyt-3 macromolecule. A detergent lysate from BALB/cNHz surface lZ~l-labeled thymocytes was immuooprecipitated with anti-Lyt-2 (53-6.7) and electrophoresed under nonreducing gel conditions in the first dimension and under reducing gel conditions in the second dimension. The first dimension tube gels were 10% DATD-acrylamide and the second dimension slab gels were 12.,5% bisacrylamide-acrylamide. The top of the figure shows a gel track of an anti-Lyt-2 immunoprecipitate run on a 10% DATD-acrylamide gel under nonreducing conditions. FI6. 5. Two-dimensional gel electrophoresis of the Lyt-2, Lyt-3 macromolecule. A detergent lysate from BALB/cNHz surface 12hi-labeled thymocytes was immunoprecipitated with anti-Lyt-2 (53-6.7). The first dimension was a charge separation with the acidic side on the right and the basic side on the left. The second dimension was 10% SDS-polyacrylamide slab gels from the top to the bottom. A, nonreducing; B, reducing.
(c) the larger multimeric forms have more carbohydrate and are more acidic due to additional sialic acid residues.
Immunoprecipitation with anti-Lyt-2 from 125I-lactoperoxidase-labeled lymph node cells showed some differences in the structure of the macromolecule compared with thymocytes. Under reducing conditions on SDS gels, the 30,000 Mr species that by analogy with thymocytes corresponds to the Lyt-3 subunit was present. However, instead of the 34,000 and 38,000 Mr species seen on thymocytes, only a protein of 38,000 Mr was seen on lymph node cells. Although this latter 38,000 Mr species migrated as a tight double band, the 34,000 Mr species seen on thymoctyes was not present on lymph node cells (results not shown). These results suggest that the Lyt-2 subunit is processed differently in thymus vs. lymph node.
The Lyt-2,Lyt-3 Macromolecule Does Not Show Allelic Exclusion. Because of the close genetic association of Lyt-2 and Lyt-3 genes with i¢ light chain loci and the haplotype exclusion demonstrated by K light chains, it was of interest to determine whether the expression of Lyt-2 and Lyt-3 antigens is regulated in a similar way, i.e., by allelic exclusion. Quantitative immunofluorescence of ( B A L B / c N H z X A K R / J ) F 1 mice (Lyt-2 a/b, Lyt-3 a/b) thymocytes and spleen cells compared with each parental strain showed that Lyt-2.2 and Lyt-3.1 do not show allelic exclusion on thymocytes or T cells (Table II) . In the heterozygote, the antigens are found on the same percentage of cells as the positive parental strain, but are expressed in lower density than on cells from the positive parental strains.
Trypsin Sensitivity of Lyt-2 and Lyt-3 Antigens on Viable Cells. Both Lyt-2 and Lyt-3 antigens are efficiently digested from viable cells with low levels of trypsin, whereas Lyt-1 is not removed under these conditions. Fig. 6 shows that Lyt-2 and Lyt-3 antigens on thymocytes exhibit differential sensitivity to trypsin. Lyt-3 antigens are cleaved more readily than Lyt-2 antigens and can be almost completely removed with >60% of Lyt-2 antigens remaining (Fig. 6) . Although the data shown were derived from assays using monoclonal antibodies, similar results were obtained using conventional anti-Lyt alloantisera from several sources (data not shown). The differential trypsin sensitivity of Lyt-2 and Lyt-3 confirms the work of Durda and Gottlieb (13) . We also observed differential trypsin sensitivity of Lyt-2 and Lyt-3 on peripheral (spleen and lymph node) T ceils (data not shown). Studies with other, argininespecific, proteases (clostridium protease, Staphylococcus aureus V8 protease) indicate that the differential sensitivity of Lyt-2 and Lyt-3 reflects cleavages at arginine-specific sites (data not shown).
Role of the Lyt-2,Lyt-3 Macromolecule on Cytotoxic T cells. Cytotoxic T cells generated in vivo against P815 mastocytoma cells were assayed for activity against 5~Cr-labeled P815 in efforts to examine the role of the Lyt-2,Lyt-3 macromolecule in the killing process. We took advantage of the selective trypsin cleavage of the Lyt-3 subunit and the ability to measure residual Lyt-2 and Lyt-3 antigens on the killer population by quantitative fluorescence to examine the relationship of cytotoxic activity to the amount of Lyt-2 and Lyt-3 antigens remaining. The results (Table III) showed that the loss of cytotoxic activity after trypsin treatment did not quantitatively parallel the * Cytotoxic effector cells at 2 × 107 cells/0.5 ml were treated with the indicated amount of trypsin for 10 rain at 37°C. :~ Cells were assayed for surface Lyt-2 and Lyt-3 using fiuorescein-conjugated 53-6.7 and 53-5 monoclonal antibodies and a FACS-II. § Blocking ofT cell killing is described in Materials and Methods.
II Lytic units were calculated as described in Materials and Methods. ¶ Significance levels calculated with the Student's t test. ** Not significant. loss of Lyt-3 antigens on the cytotoxic T cell population. After almost complete removal of Lyt-3, the cytolytic activity had decreased by -25%. These assays were repeated several times with similar results. Using a cytotoxic T cell line (L3C5; 20) rather than in vivo-generated cytotoxic T cells, we found the opposite results; the loss of cytolytic activity after trypsin treatment was more rapid than the loss of Lyt-3 antigen (A. Glasebrook, J. A. Ledbetter, and L. A. Herzenberg, unpublished data). In neither case, however, was an exact quantitative correlation seen between cleavage of Lyt-3 and loss of cytolytic activity. Table III shows that after trypsin treatment, the in vivo-generated cytotoxic effector cells could still kill, and that the blocking of killing by anti-Lyt-3 was significantly reduced, whereas the blocking of killing by anti-Lyt-2 was significantly improved. Although Lyt-3 was not detected by immunofluorescence after trypsin treatment, some blocking of killing by anti-Lyt-3 was still observed (Table III) . The blocking assay may be more sensitive than immunofluorescence for detection of low levels of surface Lyt-3. The results imply that killer T ceils with very low levels of the Lyt-3 subunit are still functional, and that the activity of the Lyt-2,Lyt-3 molecule relevant to the killing process may not reside in the Lyt-3 subunit. Discussion Lyt-2 and Lyt-3 antigens are controlled by closely linked genes (4). The results of this paper show that Lyt-2 and Lyt-3 antigens are part of the same macromolecule and that they reside on different subunits. This is unlike the situation with some other multimeric molecules such as hemoglobins, immunoglobulins, and H-2 (K or D with B2 microglobulin), in which genes controlling individual subunits are not linked. In other multimeric proteins, such as insulin or the murine leukemia virus envelope gene products, the individual subunits are both coded for by a single gene. This leads to production of a precursor polyprotein, which is processed post-translationally by proteolytic cleavage to generate the separate subunits.
Our findings, together with the previously known close linkage of Lyt-2 and Lyt-3, suggest that the biosynthesis of Lyt-2 and Lyt-3 subunits may proceed through a precursor polyprotein intermediate. Pulse-chase labeling studies could determine whether Lyt-2 and Lyt-3 subunits are synthesized as a polyprotein that is subsequently cleaved.
When analyzed under nonreducing gel conditions, the Lyt-2,Lyt-3 macromolecules are seen in a variety of multimeric forms. Because the antigen densities of Lyt-2 and Lyt-3 measured on thymocytes or T cells are equal (15) , the various multimeric forms appear to be hexamers, tetramers, and dimers consisting of equal numbers of Lyt-2 and Lyt-3 subunits. The biochemical analyses (immunoprecipitation and gel electrophoresis) reported here are performed rapidly in the cold and in the presence of protease inhibitors and alkylating reagents, so it is likely that the various multimeric forms of the macromolecule are present on the cell surface rather than being artifactually produced during the isolation procedure.
In addition to the Lyt-2,Lyt-3 multimers, we found small amounts of the monomer Lyt-3 subunit (30,000 Mr) in detergent lysates of labeled cells. Some Lyt-2+Lyt-3 -material was present also, in the form of dimers of the 34,000 and 38,000 Mr subunits. These results are qualitatively consistent with the experiments of Durda and Gottlieb (13) , who did similar anti-Lyt-2 and anti-Lyt-3 preclearing experiments. These workers concluded that Lyt-2 and Lyt-3 antigens are separable. We find that the free Lyt-3 and Lyt-2 subunits are minor species in the detergent lysates, whereas the multimeric Lyt-2,Lyt-3 forms account for almost all of the antigenic protein.
The one-and two-dimensional gel patterns that we obtain for the Lyt-2,Lyt-3 maeromolecule are very similar to those of Reilly et al. (20) . These authors identified two heavily labeled subunits of 35,000 and 30,000 Mr and a faintly labeled subunit of <30,000 Mr. Based on their charge and labeling properties, these subunits correspond to the 38,000, 34,000, and 30,000 Mr subunits seen in our experiments. The differences in apparent molecular weight most likely result from differences in the gel systems used.
Our demonstration that Lyt-2 and Lyt-3 antigens reside on separate subunits relied on the retention of antigenic activity after reduction and alkylation in the cold of the NP-40 cell lysate. In these experiments using labeled thymocytes, the 30,000 Mr subunit specifically reacted with anti-Lyt-3, whereas the 34,000 and 38,000 Mr subunits specifically reacted with anti-Lyt-2. It is most likely that these latter two subunits both have Lyt-2 antigenic determinants and arise from a post-translational processing difference involving either carbohydrate or proteolytic cleavage. This interpretation is supported by the observation that only one of the Lyt-2 subunits (38,000 Mr) was seen on lymph node T cells. Alternatively, there is the possibility that only one of the two species that coprecipitated with anti-Lyt-2 from thymocytes has the Lyt-2 determinants, whereas the other is tightly associated through strong noncovalent interactions.
Lyt-2 and Lyt-3 antigens on viable cells show differential sensitivity to trypsin cleavage. Lyt-3 antigens can be almost completely removed under conditions in which Lyt-2 antigens are only slightly affected. Our studies of in vivo-generated T killer cells after trypsin treatment suggest that the Lyt-3 subunit is not required for cytolytic activity. This conclusion derives from the observation that trypsin-treated cytotoxic T cells with <5% residual Lyt-3 retain >75% of their cytolytic activity. However, some blocking of killing with anti-Lyt-3 still occurs. Because these experiments were performed with in vivo-generated cytotoxic T cells, the effector cells represent a heterogeneous population of T cell clones. Similar studies with a cytotoxic T cell line (L3C5; 21) showed that the lyric activity was more sensitive to trypsin than was the Lyt-3 subunit. If the Lyt-3 subunit had been directly involved in antigen recognition, we would have seen parallel losses of the antigen and cytolytic activity.
The loci controlling Lyt-2 and Lyt-3 are closely linked ~o the mouse x chain genes on chromosome 6 (5-7). Although this close linkage may be fortuitous, it is also possible that V, gene products associate with the Lyt-2,Lyt-3 macromolecule. However, control of expression of these linked genes may be different because Lyt-2 and Lyt-3 are not allelically excluded (on T ceils), whereas V, (on B cells) is allelically excluded. Some evidence for light chain variable region (Vx) expression on T cells bearing the Lyt-2,Lyt-3 antigens is available (22) , but whether Vx is allelically excluded on these cells is not known.
Comparative structural and functional studies of mouse and human T cell antigens have shown that human cytotoxic/suppressor T cells have a molecule homologous to the mouse Lyt-2,Lyt-3 molecule (23, 24) . This human molecule was originally recognized by the heteroantisera used to define the TH2 + T cell subset (25) and has now been characterized by monoclonal antibodies T5 (26) , and SK1 and SK2 (23, 24) . The human Lyt-2,Lyt-3 homologue, termed Leu-2, parallels the mouse antigen in its selective expression on a functional subset of T cells and its structure as a multimeric macromolecule composed of individual disulfide-bonded subunits (23) . Furthermore, the anti-Leu-2 monoclonal antibodies (SK1 and SK2) parallel the antiLyt-2 and anti-Lyt-3 antibodies in the blocking of killing by human cytotoxic T cells in the absence of complement (24) .
The maintenance of homologous molecules on functionally distinct T cell subpopulations in two evolutionarily distant species suggests that the Lyt and Leu antigens perform essential functions for the cells on which they are found. The data so far, including (a) lack of allelic exclusion, and (b) nonparallel losses of the Lyt-3 subunit with T cell cytolytic activity after trypsin treatment, suggest that this role is something other than that of a direct antigen receptor.
Summary
Lyt-2 and Lyt-3 antigens are carried on separate disulfide-bonded subunits of the same cell surface macromolecules. These are present on thymocytes in a variety of multimeric forms consisting of disulfide-bonded dimers, tetramers, and hexamers of pairwise combinations of three subunits (30,000, 34,000, and 38,000 Mr). From reduced and alkylated Nonidet-P40 thymus extracts, a monoclonal anti-Lyt-3 precipitates only the 30,000 Mr subunit, whereas monoclonal anti-Lyt-2 antibody precipitates both the 38,000 and 34,000 Mr subunits, but not the 30,000 M~ subunit. Almost all of the Lyt-2 and Lyt-3 subunits on the cell are covalently linked by disulfide bonds. However, small amounts of the free Lyt-3 subunit was seen in some experiments. Similarly, small amounts of Lyt-2+3 -material, consisting of dimers of the 38,000 and 34,000 Mr subunits were identified. Each of the three subunits migrated with a basic charge (pI > 8) on two-dimensional gels.
Cytotoxic effector cells that are blocked by anti-Lyt-2 and anti-Lyt-3 can be treated with trypsin and other arginine-specific proteases to remove these antigens. At low concentrations of these proteases, Lyt-3 antigens are selectively removed. After selective removal of Lyt-3 antigens, cytotoxic effector cells are still active and blocking of activity by anti-Lyt-3 is significantly reduced, whereas blocking of activity by antiLyt-2 is significantly increased. Neither Lyt-2 nor Lyt-3 is allelically excluded on thymocytes or T cells. These results suggest that the Lyt-2,Lyt-3 macromolecules are associated with but do not serve as the T cell antigen receptor.
